Pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) registry

GIANCANE, GABRIELLA

Open source

DOI
10.15167/giancane-gabriella_phd2019-05-22
Published
2019
Container
Not recorded
Publisher
Universit� degli studi di Genova
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15167/giancane-gabriella_phd2019-05-22,
  title = {Pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) registry},
  author = {GIANCANE, GABRIELLA},
  year = {2019},
  doi = {10.15167/giancane-gabriella_phd2019-05-22},
  url = {https://doi.org/10.15167/giancane-gabriella_phd2019-05-22}
}

RIS

TY  - JOUR
TI  - Pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) registry
AU  - GIANCANE, GABRIELLA
PY  - 2019
DO  - 10.15167/giancane-gabriella_phd2019-05-22
UR  - https://doi.org/10.15167/giancane-gabriella_phd2019-05-22
ER  - 

APA

GABRIELLA, G. (2019). Pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) registry. https://doi.org/10.15167/giancane-gabriella_phd2019-05-22

Source records